TL;DR
Investigating the roles of sialoglycans in pregnancy and their intersection with tumors may facilitate the development of novel therapies targeting glyco-immune checkpoints for the treatment of pregnancy-related diseases, such as miscarriage and preeclampsia.
AI-generated by Semantic Scholar
Authors
Jianmei Huang, Lu Feng, Jianming Huang, Guonan Zhang, Shixiu Liao